Search Results - Richard Greil

Refine Results
  1. 1

    Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature by Konstantin Schlick, Dominik Kiem, Richard Greil

    Published in Biomolecules (2021-10-01)
    Get full text
    Article


  2. 2

    Response to comment by P. Vassilakopoulos and colleagues by Ulrich Jaeger, Michael Praxmarer, Richard Greil

    Published in Haematologica (2015-11-01)
    Get full text
    Article


  3. 3

    The effect of exercise training on endothelial function in postmenopausal women with breast cancer under aromatase inhibitor therapy by Barbara Mayr, Bernhard Reich, Richard Greil, Josef Niebauer

    Published in Cancer Medicine (2022-12-01)
    Get full text
    Article


  4. 4

    Management of metastatic colorectal cancer in patients ≥70 years - a single center experience by Florian Huemer, Celine Dunkl, Gabriel Rinnerthaler, Gabriel Rinnerthaler, Konstantin Schlick, Ronald Heregger, Klaus Emmanuel, Daniel Neureiter, Daniel Neureiter, Eckhard Klieser, Michael Deutschmann, Falk Roeder, Richard Greil, Richard Greil, Richard Greil, Lukas Weiss, Lukas Weiss, Lukas Weiss

    Published in Frontiers in Oncology (2023-07-01)
    Get full text
    Article


  5. 5

    The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation by Florian Wolff, Michael Leisch, Richard Greil, Angela Risch, Lisa Pleyer

    Published in Cell Communication and Signaling (2017-03-01)
    Get full text
    Article


  6. 6

    miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors by Florian Huemer, Michael Leisch, Roland Geisberger, Nadja Zaborsky, Richard Greil

    Published in Pharmaceuticals (2021-01-01)
    Get full text
    Article


  7. 7

    Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab‐paclitaxel as first‐line chemotherapy for advanced pancreatic adenocarcinoma: A single‐center retrospective a... by Konstantin Schlick, Antonia Gantschnigg, Alexander Seymer, Florian Huemer, Richard Greil, Lukas Weiss

    Published in Cancer Medicine (2023-08-01)
    Get full text
    Article


  8. 8

    Lysine residue at position 22 of the AID protein regulates its class switch activity. by Roland Geisberger, Michael Huemer, Franz J Gassner, Nadja Zaborsky, Alexander Egle, Richard Greil

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  9. 9

    Electrotherapy as treatment for chemotherapy-induced peripheral neuropathy — a randomized controlled trial by Robert Sassmann, Simon Peter Gampenrieder, Simon Peter Gampenrieder, Simon Peter Gampenrieder, Florian Rieder, Tim Johansson, Tim Johansson, Gabriel Rinnerthaler, Gabriel Rinnerthaler, Gabriel Rinnerthaler, Gabriel Rinnerthaler, Vanessa Castagnaviz, Vanessa Castagnaviz, Kathrin Lampl, Jürgen Herfert, Jürgen Herfert, Yvonne Theres Kienberger, Maria Flamm, Dagmar Schaffler-Schaden, Richard Greil, Richard Greil, Richard Greil

    Published in Frontiers in Neurology (2024-12-01)
    Get full text
    Article


  10. 10

    Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis by Gudrun Piringer, Gudrun Piringer, Gudrun Piringer, Florian Ponholzer, Josef Thaler, Josef Thaler, Thomas Bachleitner-Hofmann, Holger Rumpold, Holger Rumpold, Alexander de Vries, Lukas Weiss, Lukas Weiss, Richard Greil, Richard Greil, Michael Gnant, Dietmar Öfner

    Published in Frontiers in Oncology (2024-05-01)
    Get full text
    Article


  11. 11

    Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie) by Florian Huemer, Josef Thaler, Gudrun Piringer, Hubert Hackl, Lisa Pleyer, Clemens Hufnagl, Lukas Weiss, Richard Greil

    Published in BMC Cancer (2018-01-01)
    Get full text
    Article


  12. 12

    Panitumumab-associated encephalopathy after accidental intra-arterial application through dislocated Port-a-Cath device in the left ventricle by Slaven Pikija, Georg Pilz, Gerald Gschwandtner, Cornelia Rösler, Konstantin Schlick, Richard Greil, Johann Sellner, Johann Sellner

    Published in Frontiers in Neurology (2016-11-01)
    Get full text
    Article


  13. 13

    Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters. by Konstantin Schlick, Teresa Magnes, Lukas Ratzinger, Bernhard Jaud, Lukas Weiss, Thomas Melchardt, Richard Greil, Alexander Egle

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  14. 14

    Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients by Konstantin Schlick MD, Dominik Kiem MD, Florian Huemer MD, Daniel Neureiter MD, Lukas Weiss MD, Richard Greil MD

    Published in Technology in Cancer Research & Treatment (2021-09-01)
    Get full text
    Article


  15. 15

    Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft M... by Marlene Troch, Barbara Kiesewetter, Wolfgang Willenbacher, Ella Willenbacher, Armin Zebisch, Werner Linkesch, Michael Fridrik, Leonhard Müllauer, Richard Greil, Markus Raderer

    Published in Haematologica (2013-02-01)
    Get full text
    Article


  16. 16

    Cytotoxic Compounds of Two Demosponges (<i>Aplysina aerophoba</i> and <i>Spongia</i> sp.) from the Aegean Sea by Maria Orfanoudaki, Anja Hartmann, Mostafa Alilou, Naida Mehic, Marcel Kwiatkowski, Karin Jöhrer, Hieu Nguyen Ngoc, Andreas Hensel, Richard Greil, Markus Ganzera

    Published in Biomolecules (2021-05-01)
    Get full text
    Article


  17. 17

    Impact of Fusobacterium nucleatum on immune cell interactions and gene expression in colorectal cancer: a retrospective cohort study by Ronald Heregger, Florian Huemer, Florian Huemer, Richard Greil, Richard Greil, Marina Canadas-Ortega, Gernot Posselt, Gernot Posselt, Marieke E Ijsselsteijn, Christina Plattner, Dietmar Rieder, Zlatko Trajanoski, Anne Krogsdam, Eckhard Klieser, Eckhard Klieser, Daniel Neureiter, Daniel Neureiter, Silja Wessler, Silja Wessler, Lukas Weiss, Lukas Weiss, Lukas Weiss

    Published in Frontiers in Immunology (2025-09-01)
    Get full text
    Article


  18. 18

    Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study by Ulrich Jaeger, Ulrich Jaeger, Ingrid Simonitsch-Klupp, Patrick Klammer, Alexander Egle, Sonja Heibl, Peter Neumeister, Ella Willenbacher, Florian Erlsbacher, Julian Larcher-Senn, Philipp B. Staber, Edit Porpaczy, Cathrin Skrabs, Marius E. Mayerhoefer, Marius E. Mayerhoefer, Marcus Hacker, Thomas Melchardt, Michael A. Fridrik, Richard Greil, Richard Greil

    Published in Frontiers in Hematology (2024-03-01)
    Get full text
    Article


  19. 19

    Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy. by Teresa Magnes, Thomas Melchardt, Lukas Weiss, Christof Mittermair, Daniel Neureiter, Eckhard Klieser, Simon Gampenrieder, Gerhard Moser, Alexander Gaggl, Richard Greil, Alexander Egle

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  20. 20

    T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies by Dennis A. Eichenauer, Ina Bühnen, Michael Fuchs, Richard Greil, Alden Moccia, Josée. M. Zijlstra, Sylvia Hartmann, Carsten Kobe, Markus Dietlein, Andreas Engert, Peter Borchmann

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


Search Tools: